Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.

Saved in:
Bibliographic Details
Title: Serum Markers as predictors for treatment benefit in castration-resistant prostate cancer.
Authors: Szarvas T; Department of Urology, Semmelweis University, Budapest, Hungary; Department of Urology, University of Duisburg-Essen, Essen, Germany., Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria., Jagarlamudi K; Department of Anatomy, Physiology and Biochemistry, Faculty of Veterinary Medicine and Animal Sciences, Biomedical Center, Swedish University of Agricultural Sciences, Uppsala, Sweden., Styrke J; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Linder S; Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. Electronic address: Stig.Linder@liu.se.
Source: Urologic oncology [Urol Oncol] 2025 Nov; Vol. 43 (11), pp. 664.e11-664.e17. Date of Electronic Publication: 2025 Aug 06.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2496
DOI:10.1016/j.urolonc.2025.06.018